Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Isosulfan blue sentinel lymph node biopsy enables reliable lymph node harvest and multicolor flow cytometry in mice.

Created on 28 Jun 2026

Authors

Sydney Jeffs, April Espinoza, Samantha Owusu-Antwi, Alejandra Suarez-Arnedo, Tatiana Segura, Holly Lewis

Published in

Journal of immunological methods. Pages 114082. Jun 27, 2026. Epub Jun 27, 2026.

Abstract

Accurate and reproducible collection of the draining lymph nodes (DLNs) is essential for studying immune responses in preclinical models, yet technical variability and the small size of murine lymph nodes make consistent harvest challenging, particularly across users with differing surgical experience. To address this limitation, we adapted the clinical technique of isosulfan blue sentinel lymph node biopsy (IB-SLNB) for use in mice. Despite its widespread application in surgical oncology, IB has not been systemically evaluated for compatibility with fluorescence-based immunologic assays. Here, we show that IB-SLNB enables rapid and reliable identification of axillary DLNs, improving reproducibility of lymph node harvest. Importantly, IB labeling does not interfere with multicolor flow cytometry or downstream colorimetric analyses, preserving analytic fidelity. This facile, low-cost method enhances consistency in lymphatic tissue collection and supports high-quality immune profiling across diverse experimental contexts, including models of infection, cancer, and transplantation.

PMID:
42364902
Bibliographic data and abstract were imported from PubMed on 28 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement